SCHEMBL24628009

SCHEMBL24628009

CCCCCCCCCCC(CCCCCCCCCC)OC(=O)CCN(CCCCN1CCN(C)CC1)CCC(=O)OC(CCCCCCCCCC)CCCCCCCCCC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 1/20 0.43
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
BCHE P06276 1/20 0.39
LMNA P02545 3/20 0.38
ALDH1A1 P00352 1/20 0.38
USP2 O75604 1/20 0.36
GNAI3 P08754 2/20 0.36
GNAO1 P09471 2/20 0.36
GNAI1 P63096 2/20 0.36
GAA P10253 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCD Q05655 1/20 0.36
KDM5A P29375 1/20 0.36
TLR2 O60603 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627622 1.00 PAOX (0.43) PAOXMAPTMAPK1THRATHRB
SCHEMBL30966075 1.00 PAOX (0.43) PAOXMAPTMAPK1THRATHRB
SCHEMBL24627804 0.95 MAPK1 (0.44) PAOXMAPTMAPK1THRATHRB
SCHEMBL24627701 0.93 MAPT (0.41) PAOXMAPTMAPK1THRATHRB
SCHEMBL24627551 0.92 THRA (0.41) PAOXMAPTMAPK1THRATHRB
SCHEMBL24627705 0.92 ALDH1A1 (0.43) PAOXMAPTMAPK1THRATHRB
SCHEMBL24627862 0.92 GAA (0.43) MAPTMAPK1THRATHRBBCHE
SCHEMBL24628012 0.91 GAA (0.45) MAPTMAPK1THRATHRBBCHE
SCHEMBL24627743 0.90 ALDH1A1 (0.43) PAOXMAPTMAPK1THRATHRB
SCHEMBL24627759 0.90 ALDH1A1 (0.41) PAOXMAPTMAPK1THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF NPC1L1, PLA2G4A, PLA2G2A PAOX 453/4885MAPT 2748/4885MAPK1 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.